Voglicov GM Tablet SR
Voglicov GM Tablet SR
Introduction to Voglicov GM Tablet SR
Voglicov GM Tablet SR is a prescription-only medicine and is a potent triple drug combination formulated with Voglibose, Glimepiride, and Metformin hydrochloride to deliver effective control over Type II diabetes. This specialized medication is recommended for challenging cases, ensuring comprehensive management of diabetes.
Voglibose contributes by retarding the digestion and absorption of carbohydrates, Glimepiride stimulates insulin secretion, and Metformin Hydrochloride (SR) enhances insulin sensitivity. Together, they form a powerful trio targeting different aspects of glucose control, providing a multifaceted strategy against Type II diabetes.
Typically, it is taken orally, and the dosage may vary based on individual health parameters. It is often recommended to take the medication with a meal to optimize its effectiveness.
Users should be aware of potential side effects. These may include gastrointestinal discomforts such as diarrhea, abdominal pain, and nausea. Fluctuations in blood sugar levels and other reactions are possible Promptly report any adverse effects to your healthcare professional.
Individuals with specific health conditions, such as kidney or liver disorders, should exercise caution. Pregnant or breastfeeding individuals, as well as those with known allergies to any of the components, should consult their healthcare provider before starting this medication.
In the event of a missed dose, take it as soon as remembered unless it's close to the next scheduled dose. Do not double up to compensate for a missed dose.
Related Faqs
Are there any specific conditions in which Glimda-MV 2 Tablet SR should not be taken?
Patients who have a known allergy to any of the ingredients or excipients present in GlimdaMV 2 Tablet SR should refrain from using this medication It is similarly contraindicated for individuals with moderate to severe kidney disease Additionally patients with inflammatory bowel disease colonic ulcerations and underlying metabolic acidosis including diabetic ketoacidosis are also advised against taking this medicine Patients who have experienced an allergic reaction to GlimdaMV 2 Tablet SR or any of its components should avoid using this medication Furthermore individuals with significant kidney impairment should not take this medicine It is also not recommended for patients with inflammatory bowel disease colonic ulcerations or underlying metabolic acidosis such as diabetic ketoacidosis Those who have a known hypersensitivity to the ingredients or excipients in GlimdaMV 2 Tablet SR should refrain from using this medication Likewise individuals with moderate to severe kidney disease and patients with inflammatory bowel disease colonic ulcerations and underlying metabolic acidosis including diabetic ketoacidosis should avoid taking this medicine Patients who have a known allergy to any of the components or excipients of GlimdaMV 2 Tablet SR should refrain from using this medication Similarly individuals with moderate to severe kidney disease and patients who have inflammatory bowel disease colonic ulcerations and underlying metabolic acidosis including diabetic ketoacidosis should avoid taking this medicine It is imperative that patients who have a known allergic reaction to any of the ingredients or excipients of GlimdaMV 2 Tablet SR should avoid using this medication Additionally this medicine is not recommended for patients with moderate to severe kidney disease or those with inflammatory bowel disease colonic ulcerations and underlying metabolic acidosis including diabetic ketoacidosis
What are the instructions for the storage and disposal of Glimda-MV 2 Tablet SR?
To ensure the effectiveness and safety of this medication it is crucial to store it appropriately Always keep the medicine in its original packet or container making sure to tightly close it after each use Follow the storage instructions provided on the packaging or label to maintain its stability and potency Proper storage conditions can vary depending on the medication so it is important to refer to the specific guidelines outlined When it comes to disposing of any unused medication take extra care to prevent accidental consumption by pets children or other individuals Safely discard the medicine in a responsible manner as per the recommended disposal procedures By practicing proper storage and disposal methods you can play an active role in promoting medication safety for both yourself and those around you
What is Glimda-MV 2 Tablet SR?
Glimda-MV 2 Tablet SR is a combination of three medicines: Glimepiride, Metformin and Voglibose. This medicine is used in the treatment of type 2 diabetes mellitus (DM). It improves the blood glucose levels in adults when taken along with proper diet and regular exercise. Glimepiride lowers the blood glucose levels by increasing the release of insulin from the pancreas. Metformin works by lowering the glucose production in the liver and improving insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor which lowers the postprandial (after meals) glucose levels in the body. This combination is not indicated for the treatment of Type 1 DM.
What is Glimitip-MV?
GlimitipMV is a powerful combination of Glimepiride Metformin and Voglibose three potent medicines used for the treatment of type 2 diabetes mellitus DM Designed to improve blood glucose levels in adults this medication is an integral part of a comprehensive treatment plan that includes a balanced diet and regular exercise Glimepiride one of the active ingredients in GlimitipMV effectively lowers blood glucose levels by stimulating the pancreas to release more insulin This hormone plays a crucial role in regulating blood sugar levels Metformin another key component acts by reducing glucose production in the liver and improving insulin sensitivity further contributing to better glycemic control Voglibose the third ingredient in GlimitipMV is an alphaglucosidase inhibitor that efficiently lowers postprandial glucose levels By inhibiting the enzymes responsible for breaking down carbohydrates in the intestine Voglibose delays glucose absorption and helps maintain more stable blood sugar levels after meals It is important to note that GlimitipMV is specifically intended for the treatment of type 2 diabetes mellitus and should not be used for type 1 diabetes As a comprehensive combination medication GlimitipMV offers a multifaceted approach to managing diabetes and promoting better blood glucose control in affected individuals
Is it safe to take alcohol while I am also taking Voglicov GM?
It is important to note that consuming alcohol while taking Voglicov GM is not recommended as it poses potential risks to your health Combining alcohol with this medication can lead to a decrease in blood sugar levels also known as hypoglycemia which can be dangerous This is especially concerning for individuals with diabetes who are already at risk for low blood sugar Additionally the combination of Voglicov GM and alcohol increases the likelihood of developing lactic acidosis a serious condition characterized by the buildup of lactic acid in the blood Lactic acidosis can result in symptoms such as muscle pain weakness difficulty breathing and even lifethreatening complications Therefore it is crucial to refrain from consuming alcohol while taking Voglicov GM to ensure your safety and minimize potential adverse effects It is always advisable to consult your healthcare provider for personalized advice regarding the use of this medication and its interaction with alcohol
What is Voglicov GM?
Voglicov GM is a powerful medication that combines the benefits of three different drugs Glimepiride Metformin and Voglibose It is specifically designed to effectively manage type 2 diabetes mellitus DM By following a proper diet and engaging in regular exercise this medication helps to improve blood glucose levels in adults The Glimepiride component works by stimulating the release of insulin from the pancreas which in turn helps to lower blood glucose levels Metformin on the other hand reduces glucose production in the liver and enhances insulin sensitivity As an alphaglucosidase inhibitor Voglibose is responsible for decreasing postprandial glucose levels in the body However it is important to note that this combination medication is not suitable for the treatment of Type 1 DM With the unique combination of Glimepiride Metformin and Voglibose Voglicov GM offers an effective solution for managing type 2 diabetes It is an important tool in the battle against diabetes and can significantly improve the quality of life for those living with this condition
Disclaimer : This information is not a substitute for medical advice. Consult your healthcare provider before making any changes to your treatment . Do not ignore or delay professional medical advice based on anything you have seen or read on Medwiki.
Voglicov GM Tablet SR
Prescription Required
Packaging :
strip of 10 tablet sr
Manufacturer :
Coventic Pharma Private LimitedMRP :
Related Posts
1:15
5 Healthier Sugar Alternatives!
1:15
Pregnancy and Diabetes: What to Eat? | Foods to Eat for Gestational Diabetes!
1:15
Vidya Balan's Weight Loss: Proven Tips for Your Dream Body!
1:15
The Impact of long term untreated Sleep Apnea on Your Health!
1:15
The dangers of too much caffeine consumption!
1:15
Understanding Sleep Apnea: A Hidden Health Threat!
1:15
Why do I have so much discharge all of a sudden?
.svg)
